Alere Settles False Claims Suit for $33.2 Million

The GMP Letter
A A
Massachusetts-based medical device manufacturer Alere and its subsidiary Alere San Diego agreed to pay the United States more than $33 million to resolve False Claims Act allegations that Alere knowingly sold unreliable point-of-care diagnostic testing devices to hospitals.

To View This Article:

Login

Subscribe To The GMP Letter